Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Granulocyte-Colony Stimulating Factor Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4472731
  • 123 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Granulocyte-Colony Stimulating Factor in recent years and the growth of consumers' demand is expected to drive the global Granulocyte-Colony Stimulating Factor market.

Geographically, the global Granulocyte-Colony Stimulating Factor market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Granulocyte-Colony Stimulating Factor market in North America.

Significant participants active in the global Granulocyte-Colony Stimulating Factor market include: Intas Pharmaceuticals Ltd, Dr. Reddy's Laboratories, Pfizer Inc, Stada Arzneimittel AG, Biocon, Merck KGaA, Celltrion Inc, Novartis, Teva Pharmaceutical Industries Ltd, Amgen Inc, Mylan, Biocad, Dong-A Socio Group...

Global Granulocyte-Colony Stimulating Factor Market Segmentation:

Granulocyte-Colony Stimulating Factor market, by Granulocyte-Colony Stimulating Factor type:

Capsule

Tablet

Others

…

Granulocyte-Colony Stimulating Factor market, by Application:

Oncology

Blood Disorders

Growth Hormone Deficiencies

Chronic and Autoimmune Disorders

Other Applications

…

Granulocyte-Colony Stimulating Factor Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Granulocyte-Colony Stimulating Factor by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Granulocyte-Colony Stimulating Factor Market-Segmentation

4.1 By Type

4.1.1 Capsule

4.1.2 Tablet

4.1.3 Others

4.2 By End-User/Application Industry

4.2.1 Oncology

4.2.2 Blood Disorders

4.2.3 Growth Hormone Deficiencies

4.2.4 Chronic and Autoimmune Disorders

4.2.5 Other Applications

4.3 By Geography

4.3.1 North America Granulocyte-Colony Stimulating Factor Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Granulocyte-Colony Stimulating Factor Production from 2014-2020

4.3.1.2 North America Granulocyte-Colony Stimulating Factor Consumption from 2014-2020

4.3.1.3 North America Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

4.3.1.4 North America Granulocyte-Colony Stimulating Factor Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Granulocyte-Colony Stimulating Factor Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Granulocyte-Colony Stimulating Factor Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Granulocyte-Colony Stimulating Factor Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Granulocyte-Colony Stimulating Factor Production from 2014-2020

4.3.2.2 Europe Granulocyte-Colony Stimulating Factor Consumption from 2014-2020

4.3.2.3 Europe Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

4.3.2.4 Europe Granulocyte-Colony Stimulating Factor Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Granulocyte-Colony Stimulating Factor Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Granulocyte-Colony Stimulating Factor Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Granulocyte-Colony Stimulating Factor Production from 2014-2020

4.3.3.2 Asia-Pacific Granulocyte-Colony Stimulating Factor Consumption from 2014-2020

4.3.3.3 Asia-Pacific Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Granulocyte-Colony Stimulating Factor Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Granulocyte-Colony Stimulating Factor Production from 2014-2020

4.3.4.2 Latin America Granulocyte-Colony Stimulating Factor Consumption from 2014-2020

4.3.4.3 Latin America Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

4.3.4.4 Latin America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Granulocyte-Colony Stimulating Factor Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Granulocyte-Colony Stimulating Factor Production from 2014-2020

4.3.5.2 Middle East & Africa Granulocyte-Colony Stimulating Factor Consumption from 2014-2020

4.3.5.3 Middle East & Africa Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Intas Pharmaceuticals Ltd

5.1.1 Intas Pharmaceuticals Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Intas Pharmaceuticals Ltd Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Dr. Reddy's Laboratories

5.2.1 Dr. Reddy's Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Dr. Reddy's Laboratories Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Pfizer Inc

5.3.1 Pfizer Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Pfizer Inc Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Stada Arzneimittel AG

5.4.1 Stada Arzneimittel AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Stada Arzneimittel AG Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Biocon

5.5.1 Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Biocon Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Merck KGaA

5.6.1 Merck KGaA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Merck KGaA Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Celltrion Inc

5.7.1 Celltrion Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Celltrion Inc Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Novartis

5.8.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Teva Pharmaceutical Industries Ltd

5.9.1 Teva Pharmaceutical Industries Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Teva Pharmaceutical Industries Ltd Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Amgen Inc

5.10.1 Amgen Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Amgen Inc Sales, Growth Rate and Global Market Share from 2014-2020

5.11 Mylan

5.11.1 Mylan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.11.2 Mylan Sales, Growth Rate and Global Market Share from 2014-2020

5.12 Biocad

5.12.1 Biocad Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.12.2 Biocad Sales, Growth Rate and Global Market Share from 2014-2020

5.13 Dong-A Socio Group

5.13.1 Dong-A Socio Group Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.13.2 Dong-A Socio Group Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Granulocyte-Colony Stimulating Factor Market from 2021-2026

7.1 Future Forecast of Global Granulocyte-Colony Stimulating Factor Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Granulocyte-Colony Stimulating Factor Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Granulocyte-Colony Stimulating Factor Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Granulocyte-Colony Stimulating Factor Market Value ($) and Growth Rate of Granulocyte-Colony Stimulating Factor from 2014-2026

Global Granulocyte-Colony Stimulating Factor Production and Growth Rate Segment by Product Types from 2014-2026F

Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Granulocyte-Colony Stimulating Factor Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Granulocyte-Colony Stimulating Factor Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Capsule of Granulocyte-Colony Stimulating Factor

Figure Tablet of Granulocyte-Colony Stimulating Factor

Figure Others of Granulocyte-Colony Stimulating Factor

Table Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Granulocyte-Colony Stimulating Factor Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Oncology of Granulocyte-Colony Stimulating Factor

Figure Blood Disorders of Granulocyte-Colony Stimulating Factor

Figure Growth Hormone Deficiencies of Granulocyte-Colony Stimulating Factor

Figure Chronic and Autoimmune Disorders of Granulocyte-Colony Stimulating Factor

Figure Other Applications of Granulocyte-Colony Stimulating Factor

Table Global Granulocyte-Colony Stimulating Factor Production Value ($) by Regions

Table Global Granulocyte-Colony Stimulating Factor Production Value Share by Regions

Table Global Granulocyte-Colony Stimulating Factor Production by Regions

Table Global Granulocyte-Colony Stimulating Factor Production Share by Regions

Table Global Granulocyte-Colony Stimulating Factor Consumption by Regions

Table Global Granulocyte-Colony Stimulating Factor Consumption Share by Regions

Figure North America Granulocyte-Colony Stimulating Factor Production and Growth Rate from 2014-2020

Figure North America Granulocyte-Colony Stimulating Factor Consumption and Growth Rate from 2014-2020

Table North America Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

Table North America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

Table North America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

Table North America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

Figure Europe Granulocyte-Colony Stimulating Factor Production and Growth Rate from 2014-2020

Figure Europe Granulocyte-Colony Stimulating Factor Consumption and Growth Rate from 2014-2020

Table Europe Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

Table Europe Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

Table Europe Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

Table Europe Granulocyte-Colony Stimulating Factor Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Granulocyte-Colony Stimulating Factor Production and Growth Rate from 2014-2020

Figure Asia-Pacific Granulocyte-Colony Stimulating Factor Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

Table Asia-Pacific Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

Figure Latin America Granulocyte-Colony Stimulating Factor Production and Growth Rate from 2014-2020

Figure Latin America Granulocyte-Colony Stimulating Factor Consumption and Growth Rate from 2014-2020

Table Latin America Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

Table Latin America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Granulocyte-Colony Stimulating Factor Production and Growth Rate from 2014-2020

Figure Middle East & Africa Granulocyte-Colony Stimulating Factor Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Granulocyte-Colony Stimulating Factor Import and Export from 2014-2020

Table Middle East & Africa Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Granulocyte-Colony Stimulating Factor Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Granulocyte-Colony Stimulating Factor Participants Value ($) and Market Share (%) in 2019

Table Intas Pharmaceuticals Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Intas Pharmaceuticals Ltd Sales and Growth Rate from 2014-2020

Figure Intas Pharmaceuticals Ltd Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Dr. Reddy's Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Dr. Reddy's Laboratories Sales and Growth Rate from 2014-2020

Figure Dr. Reddy's Laboratories Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Inc Sales and Growth Rate from 2014-2020

Figure Pfizer Inc Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Stada Arzneimittel AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Stada Arzneimittel AG Sales and Growth Rate from 2014-2020

Figure Stada Arzneimittel AG Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Biocon Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Biocon Sales and Growth Rate from 2014-2020

Figure Biocon Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Merck KGaA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Merck KGaA Sales and Growth Rate from 2014-2020

Figure Merck KGaA Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Celltrion Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Celltrion Inc Sales and Growth Rate from 2014-2020

Figure Celltrion Inc Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Novartis Sales and Growth Rate from 2014-2020

Figure Novartis Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Industries Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Industries Ltd Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Industries Ltd Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Amgen Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Amgen Inc Sales and Growth Rate from 2014-2020

Figure Amgen Inc Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Mylan Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Mylan Sales and Growth Rate from 2014-2020

Figure Mylan Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Biocad Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Biocad Sales and Growth Rate from 2014-2020

Figure Biocad Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Dong-A Socio Group Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Dong-A Socio Group Sales and Growth Rate from 2014-2020

Figure Dong-A Socio Group Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Granulocyte-Colony Stimulating Factor Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Granulocyte-Colony Stimulating Factor Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Granulocyte-Colony Stimulating Factor Production and Growth Rate Forecast by Types (2021-2026)

Table Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390